David Apelian,Thomas H. King,Zhimin Guo,Claire Coeshott
申请号：
US15909112
公开号：
US20180311339A1
申请日:
2018.03.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.
